Intest Res.  2023 Jul;21(3):275-276. 10.5217/ir.2023.00061.

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?

• Park J

• KMID: 2544749
• DOI: http://doi.org/10.5217/ir.2023.00061

Reference

1. Koh SJ, Hong SN, Park SK, et al. Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease. Intest Res. 2023; 21:43–60.

2. Na SY, Choi CH, Song EM, et al. Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis. Intest Res. 2023; 21:61–87.

3. Targownik LE, Kaplan GG, Witt J, et al. longitudinal trends in the direct costs and health care utilization ascribable to inflammatory bowel disease in the biologic era: results from a canadian population-based analysis. Am J Gastroenterol. 2020; 115:128–137.

4. Yu H, MacIsaac D, Wong JJ, et al. Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Aliment Pharmacol Ther. 2018; 47:364–370.

5. Song EM, Yang SK. Natural history of inflammatory bowel disease: a comparison between the East and the West. Intest Res. 2022; 20:418–430.

6. Park J, Jeong GH, Song M, et al. The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: A systematic analysis for the global burden of disease study 2019. Dig Liver Dis. 2023; May. 1. [Epub]. https://doi.org/10.1016/j.dld.2023.04.003.

7. van Linschoten RCA, Visser E, Niehot CD, et al. Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents. Aliment Pharmacol Ther. 2021; 54:234–248.

8. Nakase H, Keum B, Ye BD, Park SJ, Koo HS, Eun CS. Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn’s and Colitis (AOCC) meeting in Seoul. Intest Res. 2016; 14:231–239.

9. Song EM, Na SY, Hong SN, et al. Treatment of inflammatory bowel disease—Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting. Intest Res. 2023; 21:339–352.